H Steven White

Title: H Steven White: Innovator in Metabotropic Glutamatergic Receptor Research

Introduction

H Steven White is a notable inventor based in Seattle, WA, who has made significant contributions to the field of pharmacology. He holds a total of four patents, showcasing his innovative approach to drug development and receptor modulation.

Latest Patents

Among his latest patents is a groundbreaking invention related to combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2. This invention focuses on the use of a positive allosteric modulator (PAM) of metabotropic glutamatergic receptor subtype 2 (mGluR2) or a pharmaceutically acceptable salt or solvate thereof, along with a synaptic vesicle protein 2A (SV2A) ligand. This combination aims to enhance therapeutic efficacy in treating various neurological conditions.

Career Highlights

H Steven White is currently associated with Janssen Pharmaceutica NV, where he continues to advance his research and development efforts. His work has been instrumental in exploring new avenues for drug therapies that target specific receptor subtypes.

Collaborations

He has collaborated with notable colleagues such as Brian D Klein and Hilde Lavreysen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

H Steven White's contributions to the field of pharmacology, particularly in the area of metabotropic glutamatergic receptors, highlight his role as a leading inventor. His ongoing work promises to impact the future of therapeutic interventions significantly.